PRNewswireAdvertisementSingapore, July 7: Gene Solutions, a biotechnology company advancing genomic solutions for cancer detection and precision oncology, today announced a major global milestone for SPOT-MAS 10, its AI-powered, multi-omic blood-based test for multi-cancer screening.AdvertisementA blood-based cancer screening technology developed in Asia is gaining international attention after real-world data from more than 84,145 individuals were presented at ASCO Breakthrough 2026 and highlighted by the American Society of Clinical Oncology. For Gene Solutions, this milestone underscores the growing global relevance of Asia-led multi-cancer detection innovation.AdvertisementFollowing its presentation at ASCO Breakthrough 2026 in Singapore, SPOT-MAS 10 clinical data have gained international attention through…